Table 1. FH and MED12 mutation status of 21 uterine leiomyomas from four HLRCC patients with at least one MED12 mutation-positive tumour.
Patient | Tissue material | Germ-line FH mutation | MED12 mutation status | 2SC IHC |
---|---|---|---|---|
B3 | FFPE | c.671_672delAG, p.E224fs | Wt | + |
FFPE | c.671_672delAG, p.E224fs | c.131G>A, p.G44D | − | |
FFPE | c.671_672delAG, p.E224fs | Wt | + | |
B7 | Fresh frozen | c.671_672delAG, p.E224fs | c.113-160del48, p.A38_G53del | − |
Fresh frozen | c.671_672delAG, p.E224fs | Wt | + | |
Fresh frozen | c.671_672delAG, p.E224fs | Wt | + | |
Fresh frozen | c.671_672delAG, p.E224fs | Wt | + | |
Fresh frozen | c.671_672delAG, p.E224fs | Wt | + | |
Fresh frozen | c.671_672delAG, p.E224fs | Wt | + | |
E1 | FFPE | c.587A>G, p.H196R | Wt | + |
FFPE | c.587A>G, p.H196R | Wt | + | |
FFPE | c.587A>G, p.H196R | Wt | + | |
FFPE | c.587A>G, p.H196R | Wt | + | |
FFPE | c.587A>G, p.H196R | Wt | + | |
FFPE | c.587A>G, p.H196R | c.130G>A, p.G44S | − | |
My31 | Fresh frozen | c.1439C>G, p. S480X | c.130G>A, p.G44S | − |
Fresh frozen | c.1439C>G, p. S480X | c.131G>T, p.G44V | − | |
Fresh frozen | c.1439C>G, p. S480X | IVS1-1_139del41 | − | |
Fresh frozen | c.1439C>G, p. S480X | IVS1-8T>A, p.E33_D34insPQ | − | |
Fresh frozen | c.1439C>G, p. S480X | c.131G>A, p.G44D | − | |
Fresh frozen | c.1439C>G, p. S480X | c.130G>C, p.G44R | − |
Abbreviations: FH=fumarate hydratase; FFPE=formalin-fixed paraffin-embedded; HLRCC=hereditary leiomyomatosis and renal cell cancer; IHC = immunohistochemistry; MED12=mediator complex subunit 12; wt=wild type.